ArticleScience translational medicine2022

Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.

Alexandra Schäfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.